DEBRA JOYNER: Open Payments
NPI 1457327918 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,013 in 92 payments from 24 companies in 2025. Trend: 2023 $1,553 · 2024 $833 · 2025 $2,013
Food & beverage: $2,013
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $335 |
| Lilly USA, LLC | 9 | $312 |
| Amgen Inc. | 10 | $207 |
| ABBVIE INC. | 16 | $140 |
| Phathom Pharmaceuticals, Inc. | 2 | $137 |
| Novo Nordisk Inc | 6 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $106 |
| GlaxoSmithKline, LLC. | 6 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Daiichi Sankyo Inc. | 2 | $56 |
Products named: AIRSUPRA, VOQUEZNA, ZEPBOUND, EVENITY, XIFAXAN, Ozempic, UBRELVY, OTEZLA.
Industry payments across SC — which companies pay providers there.
